Concepedia
Author
Shanooja Shanavas
Also Known As
18
Publications
129
Citations
8
H-Index
0
Concepts
All Affiliations
×
All Concepts
114
Luminescent 11-{Naphthalen-1-yl}dipyrido[3,2-a:2′,3′-c]phenazine-Based Ru(II)/Ir(III)/Re(I) Complexes for HCT-116 Colorectal Cancer Stem Cell Therapy
Utpal Das, Shanooja Shanavas, Apoorva H. Nagendra, +7
ACS Applied Bio Materials
2023
19
G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2′-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells
Nilmadhab Roy, Shanooja Shanavas, Binoy Kar, +7
ACS Omega
2-Aryl-1<i>H</i>-imidazo[4,5-<i>f</i>][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic Agents
Binoy Kar, Shanooja Shanavas, Arun Karmakar, +6
Journal of Medicinal Chemistry
2024
17
Mitochondria-targeted half-sandwich iridium(<scp>iii</scp>)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468
Ashaparna Mondal, Shanooja Shanavas, Utsav Sen, +4
RSC Advances
2022
15
Mitigation of chronic glucotoxicity-mediated skeletal muscle atrophy by arachidonic acid
Akash Mitra, Shanooja Shanavas, Debajit Chaudhury, +3
Life Sciences
12
Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment
Utpal Das, Shanooja Shanavas, Meena Jayaprakash, +10
2025
Iridium(<scp>iii</scp>)–Cp*-(imidazo[4,5-<i>f</i>][1,10]phenanthrolin-2-yl)phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem cell therapeutic agents
Binoy Kar, Shanooja Shanavas, Apoorva H. Nagendra, +12
Dalton Transactions
10
Sialic Acid-Targeted Ru(II)/Ir(III)/Re(I) Complexes for Ferroptosis Induction in Triple-Negative Breast Cancer
Nilmadhab Roy, Tiasha Dasgupta, Sreejani Ghosh, +12
Langmuir
Page 1